Member Info for Latino

Doubt it will get lower, double bottom at 0.13. Only way is up from here hopefully.

Suhail - spot on fella. CEO has deceived shareholders, and that’s unforgivable. Should go and we should reject Tranche 2 - he can keep it tranche 2 purchase...funny he didn’t want any of Tranche 1!

It’s your vote, so GL. Don’t think a minnow like BOIL have skill, resource, expertise and know how to go it alone. Seen it so many times in the past, they’re run out of money.

Either JV or sell the asset or the viable options for me, so my vote will be to REJECT Tranche 2 and see it as a no brainer!

As other posters have also pointed out, saying all afternoon. CEO cannot get away with this, he’s been dishonest with shareholder, talking of JV all year and then doing opposite by deciding to go it alone + doing this placing at monumental discount, is simply not on and taking the shareholders as dumb!

We must reject Tranche 2, company don’t need it at this stage. Then company should try and sell the asset if JV can’t be found.

Yes very quiet, but on positive news it will shoot up very quick and most likely before you know it or able to buy you will have to pay a hefty premium. Plan is agreed and passed by courts, so it is now being executed by JPLs..news could come anytime between now and court date..

Exactly my point, they don’t really need tranche 2 now. So shareholders must vote this down!

He’ll be back and so will a lot of other PIs, nothing really changed from the asset perspective, it’s bit heavily de-risked with the funding now so it’s now in a stronger position than when it was 0.12 last time round...!

The point is a decent CEO would not be doing such a discounted placing especially when SP has risen 5x folds from that price! He’s literally shafted most of the shareholders and then has the audacity to boast about the assets the excellent assets we have...it’s so mediocre it’s hard to accept! Also this is from a high SP, but would he have done if the sentiments were bad and SP around 0.1...placing at 0.02p or something!

This will recover I have no doubt as it’s asset have value, but the way the placing is done and then to say ‘oh I’ll also take part in Tranche 2 if you support the GM’ stinks....if I were him I’d dodge the GM because SH are gonna want to some serious answers!

How can he place at 0.1, seriously had chance at 0.5, 0.4, 0.3, 0.2...scandalous and I don’t know how he can have the audacity to ask for shareholder
Approval on the 10th for tranch 2...it’s outrageous!

Timing going to catch out a lot of people!

Tranch 2 needs shareholder vote, so may not happen.

Second they 0.2 finish it looks like...buyers rushing in. T-2 likely get rejected?

It’s proposed they’re awarded nothing yet, as shareholders we have to vote for appointment

For holders, it’s not worth selling is it! You might as well hold tight and give the new BoD a chance as there is nothing to lose. At least Riverfort are out which is a hugh positive, Colin out also a hugh positive, new investor putting in 800k also a positive.

Negative: JP past performance, but he will have to perform this time to restore his credibility as failing here he is surely finished!

Wrong Q...what you should be asking is that if this was so bad, who is investing near £1m into this company? Also, Riverfort warrants all cancelled. Someone is backing the new BoD, and their plan + their options..

Restructure and new BoD, all bod all literally out, so don’t understand you’re point about de-listing? Companies who’re going to de-list don’t hire new BoDs!

Ramping lol you mean genuine holders, derampers/shorters stuffed here...fact is this company is perfectly positioned to serve the world at this difficult time..

This is absolutely mega news, and the timing of this could not be any better with FDA Approval imminent! Gla

When were they listed? When did this happen all of a sudden..no RNS ?

Yes specific detection of C-Virus:

Q: How does this kit compare to others that have also recently appeared?
A: The Primerdesign 2019n-CoV kit has been designed specifically for the Wuhan specific strain, not associated strains. It shows 100% homology with the genomes of this strain that have been sequenced to date in the public domain. This includes global strains, as well as China. We have undertaken extensive bioinformatic analysis to confirm inclusivity and exclusivity parameters which have shown the Primerdesign kit to be more specific than alternative kits. For example, the WHO designed their published assay prior to knowing the 2019-nCoV sequence and as such, that assay detects other coronaviruses such as SARS-related viruses. We believe that our kit will have improved specificity over the Chinese CDC and US CDC designs as we have designed our detection profile to have a greater number of mismatches with related species. This means Primerdesign's kit will not detect other species, whereas other assays available will, and therefore have reduced specificity.